ATM serine/threonine kinase
| UniProt | Protein Name |
|---|---|
| Q13315 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| DNA damage checkpoint signaling | ||
| DNA damage checkpoint signaling | ||
| pexophagy | ||
| telomere maintenance | ||
| double-strand break repair via homologous recombination |
| GO Term | Evidence Code | PMID |
|---|---|---|
| intracellular membrane-bounded organelle | ||
| extrinsic component of synaptic vesicle membrane | ||
| DNA repair complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| DNA-dependent protein kinase activity | ||
| AMP-activated protein kinase activity | ||
| eukaryotic translation initiation factor 2alpha kinase activity | ||
| ribosomal protein S6 kinase activity | ||
| protein binding |
| Gene Ontology |
|---|
| ATP binding |
| kinase activity |
| nucleotide binding |
| phosphorylation |
| transferase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050671 | female breast cancer | |
| DOID:12704 | ataxia telangiectasia | |
| DOID:1380 | endometrial cancer | |
| DOID:14330 | Parkinson's disease | |
| DOID:1612 | breast cancer | |
| DOID:1793 | pancreatic cancer | |
| DOID:3907 | lung squamous cell carcinoma | |
| DOID:3908 | lung non-small cell carcinoma | |
| DOID:3969 | papillary thyroid carcinoma | |
| DOID:5409 | lung small cell carcinoma |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 103377587 | CYNSE22157 | ||
| 103474390 | POERE06055 | ||
| 103662421 | URSMA10530 | ||
| 103731335 | NANGA11564 | ||
| 103827295 | SERCA01494 | ||
| 104660482 | RHIRO34585 | ||
| 105021770 | ESOLU00587 | ||
| 105493755 | MACNE06053 | ||
| 105543027 | MANLE24627 | ||
| 105588729 | CERAT19421 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025